| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 04/07/2011 | WO2011041599A2 6-methylvitamin d3 analogs and their uses |
| 04/07/2011 | WO2011041590A2 1-desoxy-2-methylene-19-nor-vitamin d analogs and their uses |
| 04/07/2011 | WO2011041478A1 Hematopoietic stem cells for use in the treatment of a kidney injury |
| 04/07/2011 | WO2011040510A1 Indazole analogue |
| 04/07/2011 | WO2011040449A1 Novel phenol derivative |
| 04/07/2011 | WO2011040421A1 Screening method |
| 04/07/2011 | WO2011040004A1 Novel phenylpyridine derivative and medicinal agent comprising same |
| 04/07/2011 | WO2011038662A1 Compounds as trpv1 blockers, pharmaceutical compositions and medical uses thereof |
| 04/07/2011 | WO2010135536A9 Methods of modulating uric acid levels |
| 04/07/2011 | US20110082181 Compounds as Lysophosphatidic Acid Receptor Antagonists |
| 04/07/2011 | US20110082170 Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (vr1) and uses thereof |
| 04/07/2011 | US20110082166 Novel 4-benzhydryl-tetrahydro-pyridine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 04/07/2011 | US20110082164 Polycyclic compounds as lysophosphatidic acid receptor antagonists |
| 04/07/2011 | US20110082131 Triazole derivatives useful as axl inhibitors |
| 04/07/2011 | US20110082129 Organic compounds |
| 04/07/2011 | US20110082123 6-Methylvitamin D3 Analogs and Their Uses |
| 04/07/2011 | US20110082121 1-Desoxy-2-Methylene-19-Nor-Vitamin D Analogs and Their Uses |
| 04/07/2011 | US20110082117 Phenyl sulfonamides as modulators of ion channels |
| 04/07/2011 | US20110082110 Water-soluble benzoazepine compound and its pharmaceutical composition |
| 04/07/2011 | US20110082109 Novel acyl guanidine derivatives |
| 04/07/2011 | US20110082098 Novobiocin analogues and treatment of polycystic kidney disease |
| 04/07/2011 | US20110081426 Aminothiazole modulators of beta-3-adrenoreceptor |
| 04/07/2011 | US20110081413 Pharmaceutical Compositions Comprising Phosphate-Binding Polymer |
| 04/07/2011 | US20110081371 Angiotensin peptide-carrier conjugates and uses thereof |
| 04/07/2011 | US20110081361 Antibodies that bind interleukin-4 receptor |
| 04/07/2011 | US20110081323 Methods and compositions for organ and tissue functionality |
| 04/07/2011 | US20110081295 Peripheral-type benzodiazepine receptor expression level as an index of organ damage and regeneration |
| 04/07/2011 | DE202009018155U1 Zusammensetzung eines Kranbeeren-Derivats und D-Mannose, um Harnwegsinfektionen zu verhindern, zu kontrollieren und zu verbessern In order to prevent urinary tract infections to control composition of a cranberry derivative and D-mannose, and to improve |
| 04/07/2011 | CA2776452A1 Hematopoietic stem cells for use in the treatment of a kidney injury |
| 04/07/2011 | CA2775464A1 Indazole analog |
| 04/07/2011 | CA2775309A1 Novel phenol derivative |
| 04/06/2011 | EP2305822A2 Methods and compositions for diseases associated with Amyloidosis |
| 04/06/2011 | EP2305795A1 Method of collecting placental stem cells |
| 04/06/2011 | EP2305713A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305712A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305684A1 Poycyloalkylpurines as adenosine receptor antagonists |
| 04/06/2011 | EP2305677A1 Alkyne-aryl-naphthyridin-4(1h)-one derivatives as type IV phosphodiesterase inhibitor |
| 04/06/2011 | EP2305653A1 Therapeutic agent for chronic renal failure |
| 04/06/2011 | EP2305641A1 Sulfonamide compound or salt thereof |
| 04/06/2011 | EP2305305A1 Agent for induction/maintenance of remission |
| 04/06/2011 | EP2305276A2 Processed lipoaspirate cells for use in therapy |
| 04/06/2011 | EP2305233A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/06/2011 | EP2305232A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/06/2011 | EP2305231A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/06/2011 | EP2303930A1 A sulfated polysaccharide compound and the preparation and use thereof |
| 04/06/2011 | EP2303860A2 2-pyridyl substituted imidazoles as alk4 and/or alk4 inhibitors |
| 04/06/2011 | EP2303840A2 Calcium ion channel modulators&uses thereof |
| 04/06/2011 | EP2303306A2 Development of a c-reactive protein mutant with improved therapeutic benefit in immune thrombocytopenia and lupus nephritis |
| 04/06/2011 | EP2303302A2 A formulation and method for relieving or preventing symptoms associated with uric acid crystals |
| 04/06/2011 | EP2303301A2 Plant-based compositions and uses |
| 04/06/2011 | EP1602660B1 Aminophosphonic acid derivatives, addition salts thereof and s1p receptor modulators |
| 04/06/2011 | EP1303522B1 Biologically active macrolides, compositions, and uses thereof |
| 04/06/2011 | CN1376146B Solid-state form of celecoxil having enhanced bioavailability |
| 04/06/2011 | CN102007147A Anti-cd27 antibody |
| 04/06/2011 | CN102002048A Water-soluble anionic bacteriochlorophyll derivatives and their uses |
| 04/06/2011 | CN102002045A Pyrazolopyrimidinone derivatives as well as preparation method and application thereof |
| 04/06/2011 | CN102000277A Traditional Chinese medicine composite for treating nephritis and preparation method thereof |
| 04/06/2011 | CN102000273A Tea, granules, capsules and oral liquid for resisting fatigue and preventing and treating urinary tract infection |
| 04/06/2011 | CN102000272A Traditional Chinese medicinal preparation for treating acute nephritis |
| 04/06/2011 | CN102000199A Method for drying extract of total saponins of leaves of rehmannia glutinosa libosch |
| 04/06/2011 | CN102000190A Medicament for treating kidney stone |
| 04/06/2011 | CN102000157A Medicinal liquor with treatment and health-care functions |
| 04/06/2011 | CN102000142A Traditional Chinese medical composition for treating urinary calculi |
| 04/06/2011 | CN102000140A Novel method for synchronously quantifying matrine and oxymatrine in kuh-seng and preparations of kuh-seng |
| 04/06/2011 | CN102000088A Application of snow acid in preparation of medicament for preventing or treating kidney fibrosis |
| 04/06/2011 | CN102000041A Furadantin capsule containing quick-release component and slow-release component and preparation method thereof |
| 04/06/2011 | CN101693074B Medicament for treating nephropathy |
| 04/06/2011 | CN101618056B Great burdock achene Chinese herb soft capsule preparation and preparation method thereof |
| 04/06/2011 | CN101518625B Drug for treating toxuria |
| 04/06/2011 | CN101317676B Puffed food made of sacred lotus husk |
| 04/06/2011 | CN101273999B Jinhuakui products and uses thereof |
| 04/06/2011 | CN101259122B Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 04/06/2011 | CN101259121B Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 04/06/2011 | CN101194984B Chinese medicine composition for treating early and medium-term chronic renal failure |
| 04/06/2011 | CN101095720B Method for preparing total salvianolic acid and the application in the preventing and treating of diabetes and the complication thereof |
| 04/05/2011 | US7919513 Inhibitors of p38 |
| 04/05/2011 | US7919507 N-aroyl cyclic amines |
| 04/05/2011 | US7919459 Cardiovascular disorders; antidiabetic agents; respiratory system disorders; antagonist of protein g receptor |
| 04/05/2011 | US7919091 Lipolysis stimulated receptor (LSR) specific antibodies |
| 04/05/2011 | CA2496040C Derivatives of dioxan-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 04/05/2011 | CA2494695C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 04/05/2011 | CA2463348C Use of hydroxyoleic acid and related compounds in the manufacture of drugs |
| 04/05/2011 | CA2344168C Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 03/31/2011 | WO2011037913A2 Methods for preventing oxidative stress injury of a tissue by a folate-tempol conjugate |
| 03/31/2011 | WO2011037223A1 Agent for reducing visceral fat weight |
| 03/31/2011 | WO2011037192A1 Substituted amide compound |
| 03/31/2011 | WO2011036895A1 Maleic acid salt and crystal thereof |
| 03/31/2011 | WO2011035734A1 Relinqing extract, preparative method and use thereof |
| 03/31/2011 | WO2010066629A3 Novel azaindoles |
| 03/31/2011 | US20110077249 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives |
| 03/31/2011 | US20110077221 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
| 03/31/2011 | US20110076281 Bmp-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders |
| 03/31/2011 | US20110076234 Peptides comprising an isodgr motif |
| 03/31/2011 | DE112009000125T5 Verwendung einer Zusammensetzung eines Kranbeeren-Derivats und D-Mannose, um Harnwegsinfektionen zu verhindern, zu kontrollieren und zu verbessern In order to prevent urinary tract infections to control use of a composition of a cranberry derivative and D-mannose, and to improve |
| 03/31/2011 | CA2775027A1 Maleic acid salt and crystal thereof |
| 03/31/2011 | CA2774647A1 Substituted amide compound |
| 03/30/2011 | EP2301971A1 Antibodies that bind both BCMA and TACI |
| 03/30/2011 | EP2301970A1 Human antibodies that bind human IL-12 and methods for producing |
| 03/30/2011 | EP2301952A2 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 03/30/2011 | EP2301930A1 Thrombin receptor antagonists |